Abstract
China has become an attractive destination for R&D as new opportunities have
emerged following its WTO (World Trade Organization) accession. Development
has accelerated both industrially and scientifically, and today the Chinese
pharmaceutical market is worth around $US12 billion.
Factors fuelling the developmental growth and attracting foreign investors to
the area include low labor costs, high quality clinical data and an abundance
of R&D collaborative opportunities and facilities.
Global biotechnology within China has also undergone significant growth,
promising enormous potential for new companies. Biotechnology companies in the
country have already grown quicker than pharmaceutical companies.
The report discusses the whole of the Chinese pharmaceutical market, taking
readers through the history and current state of the healthcare system to the
regulations governing the country and its growing R&D capabilities. Detailing
the driving forces behind the pharma market and including a full breakdown of
the biopharma opportunities, including the contacts of active Chinese
companies, the report is an essential resource to understand and access this
lucrative market.
Reasons to purchase this report:
- Identify key partners
- Assess the current market opportunity
- Learn how newly implemented government changes have altered the face of
the industry
- Understand the organization and success of clinical trials in China
- Create strategies for profitable market access into China
The Chinese government also plays an instrumental role in the pharmaceutical
development of China. The introduction of WTO guidelines and protection for
intellectual property rights has caused a shift in the company structures of
China, forcing some to close business or enter into new collaborations.
Ideally suited for individuals wishing to introduce their companies into this
emerging market or review the opportunities available, this report provides a
perfect resource to identify the current pattern of the market and understand
the regulations that operate within the country.
| 
View Cart
